U.S. Renal Care Achieves 75% Site Adoption Of eConsent
Source: Medable
The collaboration among Medable, U.S. Renal Care, and a leading pharmaceutical sponsor underscores the remarkable impact of Medable's Total Consent solution in clinical trials.
By dispelling prevalent misconceptions regarding participant age, cost, and complexity, Medable's platform emerged as a versatile, rapid, and effective solution tailored to the unique needs of the elderly renal care population. This partnership serves as a testament to the transformative potential of innovative technologies in advancing healthcare outcomes.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
Medable
This website uses cookies to ensure you get the best experience on our website. Learn more